nach oben

Wiener klinische Wochenschrift

Erschienen in:

30.12.2022 | COVID-19 | main topic

Relationship between exercise capacity and impulse oscillometry parameters after COVID-19 infections

verfasst von: Ipek Candemir, MD, Pinar Ergun, MD, Mustafa Engin Şahin, MD, Harun Karamanli, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 9-10/2023

Einloggen, um Zugang zu erhalten

Summary

Background

After COVID-19 infection, persistent exercise intolerance, changes in lung function have been shown. Our aim is to investigate the correlation between impulse oscillometry (IOS) parameters and exercise capacity by using incremental and endurance shuttle walk tests (ISWT, ESWT) and investigate the factors and parameters which might have an effect on both IOS parameters and exercise capacity tests.

Method

The patients who had a history of COVID-19 were enrolled into cross-sectional study according to inclusion criteria. The IOS parameters, ISWT, ESWT, smoking status, time since COVID-19 diagnosis, length of hospital stay, forced vital capacity (FVC), forced expiratory volume in one second (FEV1), body mass index (BMI), fat-free mass index (FFMI), dyspnea, hospital anxiety-depression and fatigue severity scores were recorded.

Results

The study comprised 72 patients, 71% of whom were male, with a mean age of 54 ± 10 years. After COVID-19 diagnosis, the median duration was 3 (min: 1, max: 5) months and 51 (71%) of the patients were hospitalized. The FEV1 and FVC values were in normal range. The area of reactance (AX), resonance frequency (Fres), reactance at 20 Hz (X20) and the difference between resonance at 20 and 5 Hz (R5–20) correlated with both ISWT and ESWT. The FEV1 correlated with all IOS parameters (p < 0.05). Reactance correlated with FFMI (p = 024, r = 0.267), different according to hospitalization (p = 0.02).

Conclusion

In COVID-19 survivors, there could be correlations between IOS parameters and exercise capacity; and between these parameters and FEV and FVC. Furthermore, small airway disease with normal spirometric functions could be related to decreased exercise capacity in COVID-19 survivors regardless of concomitant diseases, BMI, smoking status and time since COVID-19 diagnosis.

World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance. 2020. https://apps.who.int/iris/handle/10665/331446 (Created 13 Mar 2020). Accessed 01.02.2022.

Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021; https://doi.org/10.1002/jmv.26368.CrossRefPubMedPubMedCentral

Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–5. https://doi.org/10.1001/jama.2020.12603.CrossRefPubMedPubMedCentral

Rinaldo RF, Mondoni M, Parazzini EM, Baccelli A, Pitari F, Brambilla E, Luraschi S, et al. Severity does not impact on exercise capacity in COVID-19 survivors. Respir Med. 2021;187:106577. https://doi.org/10.1016/j.rmed.2021.106577.CrossRefPubMedPubMedCentral

Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2021;S00123692(21):3635–7. https://doi.org/10.1016/j.chest.2021.08.010.CrossRef

Skjørten I, Ankerstjerne OAW, Trebinjac D, Brønstad E, Rasch-Halvorsen R, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58:2100996. https://doi.org/10.1183/13993003.00996-2021.CrossRefPubMedPubMedCentral

Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, Vidal-Petiot E, et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV‑2 survivors. Eur Respir J. 2021;58:2101578. https://doi.org/10.1183/13993003.01578-2021.CrossRefPubMedPubMedCentral

Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, Vilaró J. Respiratory function in patients post-infection by COVID-19: a systematic review and metaanalysis. Pulmonology. 2021;27(4):328–37. https://doi.org/10.1016/j.pulmoe.2020.10.013.CrossRefPubMed

Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, et al. Functional characteristics of patients with SARS-CoV‑2 pneumonia at 30 days post infection. Eur Respir J. 2020;56(2):2001754. https://doi.org/10.1183/13993003.01754-2020.CrossRefPubMedPubMedCentral

10.

Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, Lei C, Chen R, Zhong N, Li S. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217. https://doi.org/10.1183/13993003.01217-2020.CrossRefPubMedPubMedCentral

11.

Gupta N, Sachdev A, Gupta D. Oscillometry: a reasonable option to monitor lung functions in the era of COVID-19 pandemic. Pediatr Pulmonol. 2020;56(1):14–5.CrossRefPubMed

12.

Shirai T, Kurosawa H. Clinical application of the forced oscillation technique. Intern Med. 2016;55(6):559–66. https://doi.org/10.2169/internalmedicine.55.5876.CrossRefPubMed

13.

Yamamoto A, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, et al. Oscillometry as a predictor of exercise tolerance in COPD. Copd: J Chronic Obstr Pulm Dis. 2020;17(6):647–54. https://doi.org/10.1080/15412555.2020.1844176.CrossRef

14.

Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119(1):256–70.CrossRefPubMed

15.

Desiraju K, Agrawal A. Impulse oscillometry: the state-of-art for lung function testing. Lung India. 2016;33(4):410–6.CrossRefPubMedPubMedCentral

16.

Porojan-Suppini N, Fira-Mladinescu O, Marc M, Tudorache E, Oancea C. Lung function assessment by impulse oscillometry in adults. Ther Clin Risk Manag. 2020; https://doi.org/10.2147/TCRM.S275920.CrossRefPubMedPubMedCentral

17.

Wei X, Shi Z, Cui Y, Mi J, Ma Z, Ren J, et al. Impulse oscillometry system as an alternative diagnostic method for chronic obstructive pulmonary disease. Medicine. 2017;96(46):e8543. https://doi.org/10.1097/MD.0000000000008543.CrossRefPubMedPubMedCentral

18.

Berger KI, Reibman J, Oppenheimer BW, Vlahos I, Harrison D, Goldring RM. Lessons from the World Trade Center disaster: airway disease presenting as restrictive dysfunction. Chest. 2013;144(1):249–57.CrossRefPubMedPubMedCentral

19.

Li LY, Yan TS, Yang J, Li YQ, Fu LX, Lan L, et al. Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function. Respir Res. 2021;22:68. https://doi.org/10.1186/s12931-021-01662-7.CrossRefPubMedPubMedCentral

20.

Crisafulli R, Pisi M, Aiello M, Vigna P, Tzani A, Torres G, et al. Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration. 2017;93(1):32–41. https://doi.org/10.1159/000452479.CrossRefPubMed

21.

Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, McCormack MC, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronicrespiratory disease. Eur Respir J. 2014;44:1428–46. https://doi.org/10.1183/09031936.00150314.CrossRefPubMed

22.

American Thoracic Society, European Respiratory Society. ATS/ ERS statement on respiratory muscle testing. Am J Respir Crit Caremed. 2002;166(4):518–624. https://doi.org/10.1164/rccm.166.4.518.CrossRef

23.

Fletcher CM. Standardised questionnaire onrespiratory symptoms: a statement preparedand approved by the MRC Committee onthe etiology of Chronic Bronchitis (MRCbreathlessness score). Br Med J. 1960;2:1665.

24.

Aydemir O, Guvenir T, Kuey L. Validity and reliability of Turkish version of hospital anxiety and depression scale. T Psider. 1997;8:280–7.

25.

Gencay-Can A, Can SS. Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia. Rheumatol Int. 2012;32(1):27–31. https://doi.org/10.1007/s00296-010-1558-3.CrossRefPubMed

26.

Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, Lei C. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217. https://doi.org/10.1183/13993003.01217-2020.CrossRefPubMedPubMedCentral

27.

You J, Zhang L, Ni-jia-Ti M, Zhang J, Hu F, Chen LL. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J Infect. 2020;81(2):e150–e2. https://doi.org/10.1016/j.jinf.2020.06.003.CrossRefPubMedPubMedCentral

28.

Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G. Ïmpact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401–9. https://doi.org/10.1136/thx.2004.030205.CrossRefPubMedPubMedCentral

29.

Ong KC, Ng AWK, Lee L, Kaw G, Kwek SK. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. J Eur Respir. 2004;24(3):436–42. https://doi.org/10.1183/09031936.04.00007104.CrossRef

30.

British Thoracic Society. British thoracic society guidance on respiratory follow up of patients with a clinico-radiological diagnosis of COVID-19 pneumonia. 2020. https://www.brit-thoracic.org.uk/document-library/quality-improvement/covid-19/resp-follow-upguidance-post-covid-pneumonia/. Accessed 13.02.2022.

31.

Obling N, Rangelov B, Backer V, Hurst JR, Bodtger U. Upper airway symptoms and small airways disease in chronic obstructive pulmonary disease, COPD. Respir Med. 2022;191:106710. https://doi.org/10.1016/j.rmed.2021.106710.CrossRefPubMed

32.

Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021; https://doi.org/10.1183/13993003.00870-2021.CrossRefPubMedPubMedCentral

Titel: Relationship between exercise capacity and impulse oscillometry parameters after COVID-19 infections
verfasst von: Ipek Candemir, MD
Pinar Ergun, MD
Mustafa Engin Şahin, MD
Harun Karamanli, MD
Publikationsdatum: 30.12.2022
Verlag: Springer Vienna
Schlagwort: COVID-19
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 9-10/2023
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-022-02137-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Summary

Background

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9-10/2023

MUW researcher of the month

Impact of the COVID-19 pandemic on the epidemiology of severe burns

Physical activity levels respiratory and peripheral muscle strength and pulmonary function in young post-COVID-19 patients

Recovery and stress of control center dispatchers in the first waves of the SARS-CoV-2 pandemic

Investigating the role of obstructive pulmonary diseases and eosinophil count at admission on all-cause mortality in SARS-CoV-2 patients